Precigen (PGEN) Other Working Capital Changes (2012 - 2026)
Precigen (PGEN) posted quarterly Other Working Capital Changes of -$107000.0 for Q1 2026, down 105.14% quarter-over-quarter from $2.1 million in Q4 2025.
Analysis
Precigen (PGEN) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Other Working Capital Changes for 15 consecutive years, with -$107000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$107000.0; the TTM figure through Mar 2026 stood at $27000.0 (up 217.39% YoY), while the FY2025 annual figure was $134000.0, up 343.64% from the prior year.
- Other Working Capital Changes eased to -$107000.0 in Q1 2026 per PGEN's latest filing, from $2.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.1 million in Q2 2022 and bottomed at -$2.1 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged -$191750.0 across 5 years, with a median of -$78500.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 2010.71% — and 2025, when it surged 41540.0%.
- Precigen's Other Working Capital Changes stood at -$28000.0 in 2022, then plunged by 2010.71% to -$591000.0 in 2023, then soared by 100.85% to $5000.0 in 2024, then soared by 41540.0% to $2.1 million in 2025, then plunged by 105.14% to -$107000.0 in 2026.
- Business Quant data shows PGEN's Other Working Capital Changes at -$107000.0 in Q1 2026, $2.1 million in Q4 2025, and -$1.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -109,000.00 |
| Jun 30, 2026 | -109,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -828,000.00 |
| Dec 31, 2025 | -828,000.00 |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | -815,000.00 |
| Jun 30, 2025 | -815,000.00 |
| Mar 31, 2025 | -95,000.00 |
| Mar 31, 2025 | -95,000.00 |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | -459,000.00 |
| Jun 30, 2024 | -459,000.00 |
| Mar 31, 2024 | -699,000.00 |
| Mar 31, 2024 | -699,000.00 |